Neimeth International Pharmaceuticals Plc announced earnings results for the third quarter ended June 30, 2019. For the third quarter, the company announced sales was NGN 434.591 million compared to NGN 456.474 million a year ago. Operating income was NGN 67.400 million compared to NGN 49.655 million a year ago. Net income was NGN 25.628 million compared to NGN 30.779 million a year ago. Basic earnings per share was NGN 0.0135 compared to NGN 0.0178 a year ago. For the nine months, sales was NGN 1,410.573 million compared to NGN 1,334.704 million a year ago. Operating income was NGN 117.063 million compared to NGN 124.878 million a year ago. Net income was NGN 31.074 million compared to NGN 61.233 million a year ago. Basic earnings per share was NGN 0.0164 compared to NGN 0.0355 a year ago.